The Breast Place has participated in the NBRST study of breast cancer molecular subtyping. This technology allows the treatment team to better understand the type of tumor a woman has so that her care plan can be customized for her, including aggressive interventions when needed, and avoiding any unnecessary medications that would not be effective.
Dr Beatty and Dr Fiorini are proud to be the lead enrolling site in this groundbreaking study, and wish to thank our patients who have agreed to participate. Please read on to see the results published so far. Additional publications are expected as the follow up data for our patients are collected.